Polypoidal choroidal vasculopathy: An update on current management and review of literature
Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration (nAMD), commonly seen in the Asian population. It is dissimilar in epidemiology, genetic heterogeneity, pathogenesis, natural history, and response to treatment in comparison to nAMD. Confocal scanni...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| Series: | Taiwan Journal of Ophthalmology |
| Subjects: | |
| Online Access: | http://www.e-tjo.org/article.asp?issn=2211-5056;year=2019;volume=9;issue=2;spage=72;epage=92;aulast=Palkar |
| _version_ | 1818441903018868736 |
|---|---|
| author | Amit Harishchandra Palkar Vikas Khetan |
| author_facet | Amit Harishchandra Palkar Vikas Khetan |
| author_sort | Amit Harishchandra Palkar |
| collection | DOAJ |
| description | Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration (nAMD), commonly seen in the Asian population. It is dissimilar in epidemiology, genetic heterogeneity, pathogenesis, natural history, and response to treatment in comparison to nAMD. Confocal scanning laser ophthalmoscopy-based simultaneous fluorescein angiography and indocyanine green angiography, spectral-domain optical coherence tomography (OCT) with enhanced depth imaging, swept-source OCT, and OCT angiography have improved the ability to detect PCV, understand its pathology, and monitor treatment response. A plethora of literature has discussed the efficacy of photodynamic therapy, anti-vascular endothelial growth factor (VEGF) monotherapy, and combination of both, but only a few studies with higher level of evidence and limited follow-up duration are available. This review discusses the understanding of PCV with respect to epidemiology, pathogenesis, clinical features, natural history, imaging techniques, and various treatment options. Recent clinical trials (EVEREST-II and PLANET study) have emphasized that either anti-VEGF monotherapy or combination treatment is equally capable to strike a balance between polyp regression and stabilization of visual acuity. The recurrent nature of the disease, the development of macular atrophy, and the long-term poor visual prognosis despite treatment are concerns that open avenues for further research. |
| first_indexed | 2024-12-14T18:35:38Z |
| format | Article |
| id | doaj.art-fbe47aa5dcfb40c8a45f62329802ed65 |
| institution | Directory Open Access Journal |
| issn | 2211-5056 2211-5072 |
| language | English |
| last_indexed | 2024-12-14T18:35:38Z |
| publishDate | 2019-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Taiwan Journal of Ophthalmology |
| spelling | doaj.art-fbe47aa5dcfb40c8a45f62329802ed652022-12-21T22:51:37ZengWolters Kluwer Medknow PublicationsTaiwan Journal of Ophthalmology2211-50562211-50722019-01-0192729210.4103/tjo.tjo_35_18Polypoidal choroidal vasculopathy: An update on current management and review of literatureAmit Harishchandra PalkarVikas KhetanPolypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration (nAMD), commonly seen in the Asian population. It is dissimilar in epidemiology, genetic heterogeneity, pathogenesis, natural history, and response to treatment in comparison to nAMD. Confocal scanning laser ophthalmoscopy-based simultaneous fluorescein angiography and indocyanine green angiography, spectral-domain optical coherence tomography (OCT) with enhanced depth imaging, swept-source OCT, and OCT angiography have improved the ability to detect PCV, understand its pathology, and monitor treatment response. A plethora of literature has discussed the efficacy of photodynamic therapy, anti-vascular endothelial growth factor (VEGF) monotherapy, and combination of both, but only a few studies with higher level of evidence and limited follow-up duration are available. This review discusses the understanding of PCV with respect to epidemiology, pathogenesis, clinical features, natural history, imaging techniques, and various treatment options. Recent clinical trials (EVEREST-II and PLANET study) have emphasized that either anti-VEGF monotherapy or combination treatment is equally capable to strike a balance between polyp regression and stabilization of visual acuity. The recurrent nature of the disease, the development of macular atrophy, and the long-term poor visual prognosis despite treatment are concerns that open avenues for further research.http://www.e-tjo.org/article.asp?issn=2211-5056;year=2019;volume=9;issue=2;spage=72;epage=92;aulast=PalkarEpidemiologyimagingnatural historypathogenesispolypoidal choroidal vasculopathytreatment |
| spellingShingle | Amit Harishchandra Palkar Vikas Khetan Polypoidal choroidal vasculopathy: An update on current management and review of literature Taiwan Journal of Ophthalmology Epidemiology imaging natural history pathogenesis polypoidal choroidal vasculopathy treatment |
| title | Polypoidal choroidal vasculopathy: An update on current management and review of literature |
| title_full | Polypoidal choroidal vasculopathy: An update on current management and review of literature |
| title_fullStr | Polypoidal choroidal vasculopathy: An update on current management and review of literature |
| title_full_unstemmed | Polypoidal choroidal vasculopathy: An update on current management and review of literature |
| title_short | Polypoidal choroidal vasculopathy: An update on current management and review of literature |
| title_sort | polypoidal choroidal vasculopathy an update on current management and review of literature |
| topic | Epidemiology imaging natural history pathogenesis polypoidal choroidal vasculopathy treatment |
| url | http://www.e-tjo.org/article.asp?issn=2211-5056;year=2019;volume=9;issue=2;spage=72;epage=92;aulast=Palkar |
| work_keys_str_mv | AT amitharishchandrapalkar polypoidalchoroidalvasculopathyanupdateoncurrentmanagementandreviewofliterature AT vikaskhetan polypoidalchoroidalvasculopathyanupdateoncurrentmanagementandreviewofliterature |